TLR4 Ligands Augment Antigen-Specific CD8 + T Lymphocyte Responses Elicited by a Viral Vaccine Vector
Open Access
- 1 October 2010
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 84 (19), 10413-10419
- https://doi.org/10.1128/jvi.00928-10
Abstract
Toll-like receptor (TLR) ligands are critical activators of innate immunity and are being developed as vaccine adjuvants. However, their utility in conjunction with viral vector-based vaccines remains unclear. In this study, we evaluated the impact of a variety of TLR ligands on antigen-specific CD8 + T lymphocyte responses elicited by a recombinant adenovirus serotype 26 (rAd26) vector expressing simian immunodeficiency virus Gag in mice. The TLR3 ligand poly(I:C) suppressed Gag-specific cellular immune responses, whereas the TLR4 ligands lipopolysaccharide and monophosphoryl lipid A substantially augmented the magnitude and functionality of these responses by a MyD88- and TRIF-dependent mechanism. These data demonstrate that TLR ligands can modulate the immunogenicity of viral vaccine vectors both positively and negatively. Moreover, these findings suggest the potential utility of TLR4 ligands as adjuvants for rAd vector-based vaccines.Keywords
This publication has 42 references indexed in Scilit:
- Route of Adenovirus-Based HIV-1 Vaccine Delivery Impacts the Phenotype and Trafficking of Vaccine-Elicited CD8 + T LymphocytesJournal of Virology, 2010
- A New Adenovirus Based Vaccine Vector Expressing an Eimeria tenella Derived TLR Agonist Improves Cellular Immune Responses to an Antigenic TargetPLOS ONE, 2010
- Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in miceJCI Insight, 2010
- Viruses as vaccine vectors for infectious diseases and cancerNature Reviews Microbiology, 2009
- Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus MacaquesPLoS Pathogens, 2009
- Synthetic Toll-Like Receptor 4 Agonist Enhances Vaccine Efficacy in an Experimental Model of Toxic Shock SyndromeClinical and Vaccine Immunology, 2007
- Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and DJournal of Virology, 2007
- Pathogen Recognition and Innate ImmunityCell, 2006
- Immunogenicity of Recombinant Fiber-Chimeric Adenovirus Serotype 35 Vector-Based Vaccines in Mice and Rhesus MonkeysJournal of Virology, 2005
- Toll‐like receptor 6‐independent signaling by diacylated lipopeptidesEuropean Journal of Immunology, 2004